Kathleen A. Harrington

Cellular Models of Aggregation-dependent Template-directed Proteolysis to Characterize Tau Aggregation Inhibitors for Treatment of Alzheimer Disease

Charles R. Harrington, John M. D. Storey, S. Clunas et al. · Journal of Biological Chemistry · 2015 · 106 citations · Full text

Life Sciences, Biochemistry, Neuroscience +17

Dopamine transporter (DAT) and synaptic vesicle amine transporter (VMAT2) gene expression in the substantia nigra of control and Parkinson's disease

Kathleen A. Harrington, S.J. Augood, Ann E. Kingsbury et al. · Molecular Brain Research · 1996 · 100 citations

Life Sciences, Neurobiology, Neuroscience +17

Natural Resistance to Salmonellae in Mice: Control by Genes Within the Major Histocompatibility Complex

Carlos E. Hormaeche, Kathleen A. Harrington, Heather S. Joysey · The Journal of Infectious Diseases · 1985 · 88 citations

Life Sciences, Immunology, Infectious Diseases +12

Effects of oxidized and reduced forms of methylthioninium in two transgenic mouse tauopathy models

Valeria Melis, Mandy Magbagbeolu, Janet E. Rickard et al. · Behavioural Pharmacology · 2015 · 88 citations · Full text

Life Sciences, Neuroscience, Pharmacology +17

Human metabotropic glutamate receptor type 7: Molecular cloning and mRNA distribution in the CNS

Andrew Makoff, Charles Pilling, Kathleen A. Harrington et al. · Molecular Brain Research · 1996 · 70 citations

Life Sciences, Neurobiology, Neuroscience +16